Genki Sato

2PUBLICATIONS
5CO-AUTHORS
Epidemiological modellingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 08, 2026
Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes.

Genki Sato, Hiroshi Uchino, Kota Takuma

|Aug 07, 2024
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study.

Genki Sato, Hiroshi Uchino, Takahisa Hirose

Pageof 1